Related Experiment Video
Updated: May 23, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Speech pathology services to children with cancer and nonmalignant hematological disorders
Olivia D Taylor1, Robert S Ware, Kelly A Weir
1Royal Children's Hospital, Herston, Queensland, Australia. olivia_taylor@health.qld.gov.au
Insights
Speech pathology (SP) support is crucial for children with cancer and blood disorders. Swallowing and feeding issues were most common, particularly in those with CNS tumors or nonmalignant hematological disorders.
Area of Science:
- Pediatric Oncology
- Hematology
- Speech-Language Pathology
Background:
- Children with cancer and nonmalignant hematological disorders often need speech pathology (SP) services.
- Limited data exists on the prevalence and severity of swallowing, feeding, and communication impairments in this pediatric population.
Purpose of the Study:
- To determine the prevalence and severity of swallowing/feeding and communication impairments in children referred to SP.
- To explore associations between these impairments, specific diagnoses (oncology/hematology), and service utilization.
Main Methods:
- Retrospective chart review of 70 children referred to SP at the Queensland Children's Cancer Centre.
- Analysis of swallowing/feeding and communication dysfunction, diagnostic groups, and service delivery metrics.
Main Results:
- Swallowing/feeding disorders were the most frequent initial impairments (58.6%).
- Children with central nervous system tumors and nonmalignant hematological disorders showed significantly higher feeding impairment rates.
- Central nervous system tumors were associated with the highest rates of oral and pharyngeal dysphagia.
Conclusions:
- Speech pathology intervention is vital for pediatric cancer and hematology patients, especially those with CNS tumors.
- Further prospective research is needed to understand the long-term impact of cancer treatments on swallowing and communication functions.
Abstract:
Children with cancer and nonmalignant hematological disorders may require speech pathology (SP) support; however, limited evidence is available describing prevalence and severity of swallowing/feeding and communication impairments in this population. A retrospective chart review of 70 children referred to SP at the newly formed Queensland Children's Cancer Centre was conducted to describe the prevalence and severity of swallowing/feeding and communication dysfunction, and the association between impairment, oncology and hematology diagnosis, and service utilization (time and occasions of service). Swallowing/feeding disorders were the most commonly observed impairments at initial assessment (58.6%). Children with central nervous system tumors (P = .03) and nonmalignant hematological disorder (P = .03) had significantly higher rates of feeding impairment than other oncology and hematology diagnostic groups. Children with central nervous system tumors had the highest rates of oral phase (P = .01) and pharyngeal phase (P = .01) dysphagia (swallowing disorder). No significant difference was found between diagnostic groups for intensity of SP service delivery. Prospective research is required to examine prevalence and severity of disorders, and service utilization in a more established clinic, and to investigate interactions between cancer treatment and swallowing/feeding and communication dysfunction.
More Related Videos
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers